Expert Consensus on Rare Disease Pharmaceutical Care in Hospitals (2025)
In recent years, with strong support from the national government, the diagnosis and treatment of rare diseases in China have achieved significant progress. However, only 5% of rare diseases worldwide have effective treatments, and poor drug accessibility remains a major challenge in the field of ra...
Saved in:
| Main Author: | Rare Disease Drug Committee of the Chinese Pharmaceutical Association |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2025-05-01
|
| Series: | Xiehe Yixue Zazhi |
| Subjects: | |
| Online Access: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0252 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hospital administrators as forgotten partners in rare disease care: a call to action by the international hospital federation’s global rare pediatric disease network
by: Andrea Stoesz, et al.
Published: (2024-12-01) -
The Application of Digital Intelligence Technology in the Management of Non-Hospitalized Patients with Rare Diseases
by: YAO Yiyang, et al.
Published: (2025-01-01) -
Specific drugs for rare diseases in a province of eastern China under catalog management: from 2021 to 2023
by: Ruifang Nie, et al.
Published: (2025-03-01) -
Pharmaceutical care practice in patients with chronic kidney disease
by: Dadier Antonio Arroyo Monterroza, et al.
Published: (2017-04-01) -
Quantifying hope: an EU perspective of rare disease therapeutic space and market dynamics
by: Emmanuelle Cacoub, et al.
Published: (2025-02-01)